Expression and Localization of Opioid Receptors in Male Germ Cells and the Implication for Mouse Spermatogenesis

PLoS One. 2016 Mar 31;11(3):e0152162. doi: 10.1371/journal.pone.0152162. eCollection 2016.

Abstract

The presence of endogenous opioid peptides in different testicular cell types has been extensively characterized and provides evidence for the participation of the opioid system in the regulation of testicular function. However, the exact role of the opioid system during the spermatogenesis has remained controversial since the presence of the mu-, delta- and kappa-opioid receptors in spermatogenic cells was yet to be demonstrated. Through a combination of quantitative real-time PCR, immunofluorescence, immunohistochemistry and flow cytometry approaches, we report for the first time the presence of active mu-, delta- and kappa-opioid receptors in mouse male germ cells. They show an exposition time-dependent response to opioid agonist, hence suggesting their active involvement in spermatogenesis. Our results contribute to understanding the role of the opioid receptors in the spermatogenesis and could help to develop new strategies to employ the opioid system as a biochemical tool for the diagnosis and treatment of male infertility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Male
  • Mice
  • Real-Time Polymerase Chain Reaction
  • Receptors, Opioid, delta / agonists
  • Receptors, Opioid, delta / analysis*
  • Receptors, Opioid, delta / genetics
  • Receptors, Opioid, kappa / agonists
  • Receptors, Opioid, kappa / analysis*
  • Receptors, Opioid, kappa / genetics
  • Receptors, Opioid, mu / agonists
  • Receptors, Opioid, mu / analysis*
  • Receptors, Opioid, mu / genetics
  • Spermatogenesis* / drug effects
  • Spermatozoa / cytology*
  • Spermatozoa / drug effects
  • Spermatozoa / metabolism
  • Testis / cytology*
  • Testis / drug effects
  • Testis / metabolism

Substances

  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu

Grants and funding

This work was supported by grants from The Basque Government, University of the Basque Country (UPV/EHU) and Merck Serono. HE was supported by a fellowship from the Gangoti Barrera Foundation; MG was supported by a fellowship from Basque Government (Zabalduz); IM was supported by a fellowship from Basque Government and IU was supported by a fellowship from University of Basque Country (UPV/EHU). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.